{"id":528962,"date":"2010-04-15T18:29:42","date_gmt":"2010-04-15T22:29:42","guid":{"rendered":"http:\/\/www.xconomy.com\/?p=73826"},"modified":"2010-04-15T18:29:42","modified_gmt":"2010-04-15T22:29:42","slug":"mirabilis-nabs-1m-for-ultrasound","status":"publish","type":"post","link":"https:\/\/mereja.media\/index\/528962","title":{"rendered":"Mirabilis Nabs $1M for Ultrasound"},"content":{"rendered":"\n
Biotech<\/a>, Devices<\/a>, Ultrasound<\/a><\/div>\n

\t\tLuke Timmerman wrote:<\/strong><\/p>\n

Mirabilis Medica, the Bothell, WA-based developer of ultrasound technology to treat uterine fibroids, has raised $1 million in debt and options out of a financing round that could be worth $2 million, according to a regulatory filing<\/a>. This company, which Xconomy profiled last June<\/a>, said last year it had raised $11 million since inception from backers that include Charter Life Sciences, Arboretum Ventures, Split Rock Partners, and Dow Chemical.<\/p>\n

Comments<\/a> | Reprints<\/a> | Share:  
\n\"Retweet\"\/<\/a>
\n \"Facebook\"\/<\/a>
\n \"Email\"\/<\/a>
\n \"Share\"\/<\/a>\n<\/div>\n

UNDERWRITERS AND PARTNERS
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t<\/a>
\n\t\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t<\/a>
\n\t\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t<\/a>
\n\t\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t<\/a>
\n\t\t\t\t\t\t<\/p>\n

\t\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t<\/a>
\n\t\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t<\/a>
\n\t\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t<\/a>
\n\t\t\t\t\t\t\t\t\t

\n

\n\"\"<\/a>
\n\"\"<\/p>\n

<\/img><\/a>
\n<\/img><\/a><\/p>\n

<\/p>\n","protected":false},"excerpt":{"rendered":"

Biotech, Devices, Ultrasound Luke Timmerman wrote: Mirabilis Medica, the Bothell, WA-based developer of ultrasound technology to treat uterine fibroids, has raised $1 million in debt and options out of a financing round that could be worth $2 million, according to a regulatory filing. This company, which Xconomy profiled last June, said last year it had […]<\/p>\n","protected":false},"author":1192,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[7],"tags":[],"class_list":["post-528962","post","type-post","status-publish","format-standard","hentry","category-news"],"_links":{"self":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts\/528962","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/users\/1192"}],"replies":[{"embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/comments?post=528962"}],"version-history":[{"count":0,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts\/528962\/revisions"}],"wp:attachment":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/media?parent=528962"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/categories?post=528962"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/tags?post=528962"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}